Related Experiment Video
Updated: Jun 30, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Myocardial fibrosis in right heart dysfunction
Lucia Agoston-Coldea1, Andra Negru1
1Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Insights
Cardiac fibrosis, a cause of right heart dysfunction, can be detected and monitored using circulating biomarkers. This review explores protein and miRNA markers for understanding pathophysiology and developing therapeutics to reverse cardiac fibrosis.
Area of Science:
- Cardiology
- Biomarkers
- Fibrosis Research
Background:
- Cardiac fibrosis contributes to right heart dysfunction, leading to significant morbidity and mortality.
- Fibrosis is driven by cellular and humoral stimuli, involving various immune cells and leading to extracellular matrix modification.
- Current detection relies on advanced imaging, but circulating biomarkers offer a cost-effective alternative.
Conclusions:
- Circulating biomarkers offer a promising, accessible approach for managing cardiac fibrosis.
- Understanding biomarker roles is crucial for developing targeted antifibrotic therapies.
- Biomarkers can facilitate early detection and monitoring, potentially reversing cardiac fibrosis and improving patient outcomes.
Abstract:
Cardiac fibrosis, associated with right heart dysfunction, results in significant morbidity and mortality. Stimulated by various cellular and humoral stimuli, cardiac fibroblasts, macrophages, CD4+ and CD8+ T cells, mast and endothelial cells promote fibrogenesis directly and indirectly by synthesizing numerous profibrotic factors. Several systems, including the transforming growth factor-beta and the renin-angiotensin system, produce type I and III collagen, fibronectin and α-smooth muscle actin, thus modifying the extracellular matrix. Although magnetic resonance imaging with gadolinium enhancement remains the gold standard, the use of circulating biomarkers represents an inexpensive and attractive means to facilitate detection and monitor cardiovascular fibrosis. This review explores the use of protein and nucleic acid (miRNAs) markers to better understand underlying pathophysiology as well as their role in the development of therapeutics to inhibit and potentially reverse cardiac fibrosis.
More Related Videos
10:39Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
10:18Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pathophysiology of Heart Failure
Pathophysiology of Cardiac Performance